Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Atria | 4 | 2025 | 327 | 1.680 |
Why?
|
| Fibrosis | 6 | 2025 | 393 | 1.370 |
Why?
|
| Atrial Fibrillation | 7 | 2025 | 694 | 1.310 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 2316 | 1.180 |
Why?
|
| Atrial Remodeling | 1 | 2024 | 14 | 0.880 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2024 | 92 | 0.860 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2024 | 23 | 0.860 |
Why?
|
| Proteomics | 3 | 2025 | 561 | 0.850 |
Why?
|
| Precision Medicine | 1 | 2024 | 345 | 0.700 |
Why?
|
| Myocytes, Cardiac | 2 | 2025 | 609 | 0.660 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2020 | 93 | 0.600 |
Why?
|
| Extracellular Matrix | 4 | 2024 | 223 | 0.580 |
Why?
|
| Gene Expression Regulation | 3 | 2024 | 2324 | 0.570 |
Why?
|
| Actins | 1 | 2020 | 312 | 0.550 |
Why?
|
| Signal Transduction | 4 | 2025 | 4446 | 0.490 |
Why?
|
| Crohn Disease | 3 | 2024 | 283 | 0.470 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 756 | 0.450 |
Why?
|
| Fibroblasts | 4 | 2025 | 819 | 0.380 |
Why?
|
| Macrophages | 2 | 2025 | 643 | 0.350 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4419 | 0.260 |
Why?
|
| Mice | 7 | 2025 | 17528 | 0.250 |
Why?
|
| Myofibroblasts | 2 | 2024 | 59 | 0.240 |
Why?
|
| Animals | 11 | 2025 | 33094 | 0.240 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2025 | 15 | 0.240 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2025 | 45 | 0.230 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 1774 | 0.230 |
Why?
|
| Atrial Function, Left | 1 | 2024 | 32 | 0.220 |
Why?
|
| Milk Proteins | 1 | 2024 | 83 | 0.210 |
Why?
|
| Antigens, Surface | 1 | 2024 | 114 | 0.210 |
Why?
|
| Histological Techniques | 1 | 2023 | 19 | 0.210 |
Why?
|
| Cardiomegaly | 1 | 2024 | 119 | 0.210 |
Why?
|
| Protein Interaction Maps | 1 | 2024 | 91 | 0.210 |
Why?
|
| Receptors, Cell Surface | 1 | 2025 | 423 | 0.200 |
Why?
|
| Postoperative Complications | 2 | 2025 | 2974 | 0.200 |
Why?
|
| Calcium Signaling | 1 | 2025 | 240 | 0.200 |
Why?
|
| Interleukin-6 | 1 | 2025 | 404 | 0.200 |
Why?
|
| Inflammation Mediators | 1 | 2024 | 223 | 0.200 |
Why?
|
| Erythrocytes | 1 | 2023 | 187 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 327 | 0.190 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2025 | 239 | 0.190 |
Why?
|
| Antihypertensive Agents | 1 | 2025 | 389 | 0.190 |
Why?
|
| Proteome | 1 | 2024 | 273 | 0.180 |
Why?
|
| Heart Rate | 1 | 2025 | 563 | 0.180 |
Why?
|
| Colitis | 1 | 2023 | 156 | 0.180 |
Why?
|
| Cells, Cultured | 3 | 2025 | 2896 | 0.180 |
Why?
|
| Interleukin-1 | 1 | 2021 | 131 | 0.170 |
Why?
|
| Intestines | 2 | 2023 | 581 | 0.170 |
Why?
|
| Muscle, Smooth | 1 | 2021 | 129 | 0.160 |
Why?
|
| Calcium | 1 | 2025 | 1019 | 0.160 |
Why?
|
| Inflammation | 2 | 2024 | 1428 | 0.160 |
Why?
|
| Adipocytes | 1 | 2021 | 168 | 0.160 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2020 | 74 | 0.160 |
Why?
|
| Blood Pressure | 1 | 2025 | 1302 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 412 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 276 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 318 | 0.140 |
Why?
|
| Cell Movement | 1 | 2021 | 842 | 0.130 |
Why?
|
| Hypertension | 1 | 2025 | 1281 | 0.130 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1599 | 0.120 |
Why?
|
| Male | 5 | 2025 | 61966 | 0.100 |
Why?
|
| Action Potentials | 2 | 2025 | 459 | 0.100 |
Why?
|
| Humans | 11 | 2025 | 125613 | 0.090 |
Why?
|
| Biomarkers | 1 | 2020 | 3130 | 0.080 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2025 | 20 | 0.060 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2025 | 41 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2025 | 139 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2025 | 225 | 0.050 |
Why?
|
| Cell Separation | 1 | 2023 | 218 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2025 | 215 | 0.050 |
Why?
|
| Cell Death | 1 | 2023 | 232 | 0.050 |
Why?
|
| Adhesiveness | 1 | 2022 | 13 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 223 | 0.050 |
Why?
|
| Female | 2 | 2025 | 67790 | 0.040 |
Why?
|
| Collagen | 1 | 2022 | 294 | 0.040 |
Why?
|
| Fibronectins | 1 | 2021 | 95 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2023 | 415 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2021 | 80 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2021 | 395 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2021 | 91 | 0.040 |
Why?
|
| Rats | 1 | 2024 | 3388 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2021 | 475 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3702 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 4495 | 0.030 |
Why?
|
| Phenotype | 1 | 2025 | 4295 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 3248 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1689 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1848 | 0.030 |
Why?
|
| Risk Factors | 1 | 2025 | 10346 | 0.020 |
Why?
|
| Child | 1 | 2022 | 25015 | 0.010 |
Why?
|